Charles River Laboratories Intl (CRL)

Charles River Laboratories stock has notably lagged behind the broader market over the past year, yet analysts remain moderately optimistic about the stock’s prospects.

Charles River Laboratories International, Inc. CRL expands its products and services across the drug discovery and early-stage development continuum through targeted partnerships and acquisitions. The...

June S&P 500 E-Mini futures (ESM25) are up +1.06%, and June Nasdaq 100 E-Mini futures (NQM25) are up +1.35% this morning as sentiment got a boost after U.S. President Donald Trump said the U.S. has reached...

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. June E-mini S&P...

The S&P 500 Index ($SPX ) (SPY ) today is up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. June E-mini S&P futures (ESM25...

The S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.12%. June E-mini S&P futures (ESM25...

Charles River: Q1 Earnings Snapshot

Charles River Laboratories is scheduled to announce its first-quarter results next week, with analysts anticipating a single-digit earnings dip.

3 Cash-Producing Stocks That Concern Us

Amid market turbulence and policy shifts, do two of the S&P 500’s steepest decliners, DECK and CRL, offer deep value or signal deeper trouble ahead?